Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
European Journal of Clinical Pharmacology|November 23, 2006
Impact of high dose statin trials on hospital prescribersThomas I Barron, Kathleen Bennett, John FeelyTherapeutic Advances in Medical Oncology|May 17, 2012
Beta-adrenergic blocking drugs in breast cancer: a perspective reviewThomas I Barron, Linda Sharp, Kala VisvanathanCancer Causes & Control : CCC|February 18, 2017
Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I-III breast cancer?Caitriona Cahir, Thomas I Barron, Linda Sharp, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 20, 2017
Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-lifeAmelia Smith, Laura Murphy, Kathleen Bennett, et al.Cancer Epidemiology|January 9, 2014
Metformin exposure and disseminated disease in patients with colorectal cancerSusan Spillane, Kathleen Bennett, Linda Sharp, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 12, 2013
A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancerSusan Spillane, Kathleen Bennett, Linda Sharp, et al.BJU International|August 14, 2013
A cohort study of digoxin exposure and mortality in men with prostate cancerEvelyn M Flahavan, Linda Sharp, Kathleen Bennett, et al.Cancer|May 6, 2016
Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialMarie C Bradley, Amanda Black, Andrew N Freedman, et al.British Journal of Cancer|July 20, 2017
Pre-diagnostic statin use, lymph node status and mortality in women with stages I-III breast cancerAmelia Smith, Laura Murphy, Lina Zgaga, et al.Cancer|January 24, 2007
Early discontinuation of tamoxifen: a lesson for oncologistsThomas I Barron, Róisín Connolly, Kathleen Bennett, et al.Pageof 2